Dentsply Sirona director granted phantom stock units

MAZELSKY JONATHAN JAY reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

MAZELSKY JONATHAN JAY reported acquisition or exercise transactions in this Form 4 filing.

DENTSPLY SIRONA Inc. director Jonathan Jay Mazelsky received a grant of phantom stock under the Directors' Deferred Compensation program. The award covers 2,644.6402 phantom stock units at an economic reference price of $11.34 per unit, each tied to one share of common stock.

Following this compensation grant, his balance in this phantom stock account increased to 17,179.8540 units. According to the terms, these phantom stock units are economically equivalent to common shares and will be settled in common stock after his termination of service as a director.

Insider Trade Summary

Grant/Award: 2,644.6402 shares

Grant/Award 1 txn

Insider MAZELSKY JONATHAN JAY

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock (Directors' Deferred Compensation) DDC	2,644.6402	$11.34	$30K

Holdings After Transaction: Phantom Stock (Directors' Deferred Compensation) DDC — 17,179.854 contracts (Direct)

Footnotes (2)

1. F1. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock following the reporting person's termination of service as a director.
2. F2. Comprised of phantom stock.

Key Figures

Phantom stock units granted: 2,644.6402 units Reference price per unit: $11.34 per unit Total phantom stock after grant: 17,179.8540 units +1 more

4 metrics

Phantom stock units granted 2,644.6402 units Directors' Deferred Compensation grant on March 31, 2026

Reference price per unit $11.34 per unit Grant valuation for phantom stock award

Total phantom stock after grant 17,179.8540 units Balance following the reported transaction

Underlying common stock equivalent 2,644.6402 shares Each phantom unit equals one common share economically

Key Terms

Phantom Stock, Directors' Deferred Compensation, economic equivalent, termination of service

4 terms

Phantom Stock financial

"Each share of phantom stock is the economic equivalent of one share of common stock."

A phantom stock is a form of compensation that gives employees or executives the benefits of stock ownership, such as the increase in stock value, without actually giving them real shares. It acts like a promise to pay the employee the equivalent value of company stock later, often as a bonus or incentive. This allows companies to motivate and reward staff without diluting ownership or transferring actual shares.

Directors' Deferred Compensation financial

"Phantom Stock (Directors' Deferred Compensation) DDC"

economic equivalent financial

"Each share of phantom stock is the economic equivalent of one share of common stock."

termination of service financial

"become payable in common stock following the reporting person's termination of service as a director."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did XRAY director Jonathan Mazelsky report in this Form 4?

Jonathan Mazelsky reported receiving a grant of phantom stock units as director compensation. He acquired 2,644.6402 phantom stock units, each economically equivalent to one share of DENTSPLY SIRONA common stock, increasing his total phantom stock balance to 17,179.8540 units.

How many phantom stock units did the XRAY director receive?

He received 2,644.6402 phantom stock units. Each unit is economically equivalent to one share of DENTSPLY SIRONA common stock, and the award is part of the Directors' Deferred Compensation program, reflected as a routine compensation-related acquisition rather than an open-market stock purchase.

At what reference price were the XRAY phantom stock units credited?

The phantom stock units were credited at a reference price of $11.34 per unit. This price is used to determine the number of units granted under the deferred compensation program, not as an open-market trade price for buying or selling common shares.

What is the director’s total phantom stock balance after this XRAY grant?

After this grant, his phantom stock balance is 17,179.8540 units. These units track the value of DENTSPLY SIRONA common stock and represent deferred compensation that will be paid out in common shares when his board service eventually ends.

When will the XRAY phantom stock units be paid to the director?

The phantom stock units become payable in common stock after the director’s termination of service. Until that point, they function as deferred compensation tied economically to DENTSPLY SIRONA’s common shares rather than as currently exercisable or tradable stock.

Does this XRAY Form 4 show an open-market stock purchase or sale?

No, the filing shows a grant of phantom stock as deferred director compensation, coded as an acquisition (A). It is not an open-market purchase or sale of common shares, but a derivative compensation award economically linked to the stock price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 05:09 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MAZELSKY JONATHAN JAY

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NORTH CAROLINA 28277

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock (Directors' Deferred Compensation) DDC	(1)	03/31/2026		A		2,644.6402(2)		(1)	(1)	Common Stock	2,644.6402	$11.34	17,179.854	D

Explanation of Responses:

1. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock following the reporting person's termination of service as a director.

2. Comprised of phantom stock.

	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Jonathan Jay Mazelsky	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)